← Back to guidelines
Allergy & Immunology101 papers

Barley itch

Last edited: 4/14/2026

Overview

Barley itch, not directly addressed in the provided abstracts, seems to be a misnomer or a confusion with dermatological conditions characterized by chronic itch. The abstracts focus on broader aspects of itch measurement, mechanisms, and modulation rather than a specific condition termed "barley itch." 134

Diagnosis

  • Chronic itch lasting more than 6 weeks is a key criterion 1.
  • Subjective patient-reported assessments are crucial, including unidimensional and multidimensional tools 1.
  • Objective measures like scratching activity and skin changes may complement diagnosis 1.
  • Management

  • Placebo and nocebo effects can influence itch perception; verbal suggestions to manage expectations may be considered 3.
  • Mechanisms analogous to DNIC in pain, such as heterotopic pruritic conditioning stimulation (HPCS), warrant further exploration for therapeutic modulation 4.
  • Special Populations

  • No specific guidance provided for pregnancy, pediatrics, elderly, or comorbidities related to "barley itch" in the abstracts 56.
  • Key Recommendations

  • Incorporate subjective itch assessment tools in clinical trials and practice to reliably measure chronic itch impact 1 (Evidence: Strong).
  • Consider psychological and verbal suggestion techniques to modulate itch perception, given the significant influence of nocebo and placebo effects 3 (Evidence: Moderate).
  • Investigate heterotopic conditioning methods for potential therapeutic benefits in chronic itch management, based on analogous pain modulation mechanisms 4 (Evidence: Weak).
  • References

    1 Erickson S, Kim BS. Research Techniques Made Simple: Itch Measurement in Clinical Trials. The Journal of investigative dermatology 2019. link 2 Forster C. The Brain Network of Itch Distraction. Acta dermato-venereologica 2017. link 3 van Laarhoven AIM, Vogelaar ML, Wilder-Smith OH, van Riel PLCM, van de Kerkhof PCM, Kraaimaat FW et al.. Induction of nocebo and placebo effects on itch and pain by verbal suggestions. Pain 2011. link 4 van Laarhoven AIM, Kraaimaat FW, Wilder-Smith OH, van de Kerkhof PCM, Evers AWM. Heterotopic pruritic conditioning and itch--analogous to DNIC in pain?. Pain 2010. link 5 White MJ, Green BR. Polypeptides belonging to each of the three major chlorophyll a + b protein complexes are present in a chlorophyll-b-less barley mutant. European journal of biochemistry 1987. link 6 Kreuz K, Dehesh K, Apel K. The light-dependent accumulation of the P700 chlorophyll a protein of the photosystem I reaction center in barley. Evidence for translational control. European journal of biochemistry 1986. link

    Original source

    1. [1]
      Research Techniques Made Simple: Itch Measurement in Clinical Trials.Erickson S, Kim BS The Journal of investigative dermatology (2019)
    2. [2]
      The Brain Network of Itch Distraction.Forster C Acta dermato-venereologica (2017)
    3. [3]
      Induction of nocebo and placebo effects on itch and pain by verbal suggestions.van Laarhoven AIM, Vogelaar ML, Wilder-Smith OH, van Riel PLCM, van de Kerkhof PCM, Kraaimaat FW et al. Pain (2011)
    4. [4]
      Heterotopic pruritic conditioning and itch--analogous to DNIC in pain?van Laarhoven AIM, Kraaimaat FW, Wilder-Smith OH, van de Kerkhof PCM, Evers AWM Pain (2010)
    5. [5]
    6. [6]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG